Louis Desjardins

Summary

Affiliation: University of Montreal
Country: Canada

Publications

  1. ncbi request reprint Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study
    Louis Desjardins
    Service hématologie, CHU Laval, Ste Foy, Quebec, Canada
    Arch Pathol Lab Med 128:519-26. 2004
  2. ncbi request reprint Prospective evaluation of health-related quality of life in patients with deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    Arch Intern Med 165:1173-8. 2005
  3. ncbi request reprint VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    J Clin Epidemiol 59:1049-56. 2006
  4. ncbi request reprint Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    Ann Intern Med 149:698-707. 2008
  5. ncbi request reprint Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study
    Raza Alikhan
    Academic Department of Surgery, Guy s, King s, St Thomas School of Medicine, London, UK
    Blood Coagul Fibrinolysis 14:341-6. 2003
  6. ncbi request reprint Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
    Raza Alikhan
    Academic Department of Surgery, Guy s, King s, and St Thomas School of Medicine, London, England
    Arch Intern Med 164:963-8. 2004
  7. ncbi request reprint Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
    Susan R Kahn
    Department of Medicine, McGill University, SMBD Jewish General Hospital, Canada
    Thromb Res 119:145-55. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study
    Louis Desjardins
    Service hématologie, CHU Laval, Ste Foy, Quebec, Canada
    Arch Pathol Lab Med 128:519-26. 2004
    ..Plasma anti-Xa and anti-IIa activities correlate with the dose of low-molecular-weight heparin, and D-dimer and thrombin-antithrombin complexes are markers of procoagulant activity...
  2. ncbi request reprint Prospective evaluation of health-related quality of life in patients with deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    Arch Intern Med 165:1173-8. 2005
    ..To our knowledge, the burden of deep venous thrombosis from the patient's perspective has not been quantified. We evaluated health-related quality of life (QOL) after deep vein thrombosis and compared results with general population norms...
  3. ncbi request reprint VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
    J Clin Epidemiol 59:1049-56. 2006
    ..To assess the validity of VEINES-QOL/Sym, a patient-reported questionnaire to evaluate quality of life and symptoms in patients with deep venous thrombosis (DVT)...
  4. ncbi request reprint Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis
    Susan R Kahn
    Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
    Ann Intern Med 149:698-707. 2008
    ..The reason some patients with deep venous thrombosis (DVT) develop the postthrombotic syndrome is not well understood...
  5. ncbi request reprint Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study
    Raza Alikhan
    Academic Department of Surgery, Guy s, King s, St Thomas School of Medicine, London, UK
    Blood Coagul Fibrinolysis 14:341-6. 2003
    ..22 (95% CI, 0.09-0.51); immobility, 0.53 (95% CI, 0.14-1.72); previous VTE, 0.49 (95% CI, 0.15-1.68); and cancer, 0.50 (95%o CI, 0.14-1.72). The beneficial effects of enoxaparin extend to a wide range of acutely ill medical patients...
  6. ncbi request reprint Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study
    Raza Alikhan
    Academic Department of Surgery, Guy s, King s, and St Thomas School of Medicine, London, England
    Arch Intern Med 164:963-8. 2004
    ..There is limited information about risk factors for venous thromboembolism (VTE) in acutely ill hospitalized general medical patients...
  7. ncbi request reprint Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada
    Susan R Kahn
    Department of Medicine, McGill University, SMBD Jewish General Hospital, Canada
    Thromb Res 119:145-55. 2007
    ..Venous thromboembolism (VTE) prophylaxis in acutely ill medical patients has been shown to be safe and effective. Underutilization of this patient safety practice may result in avoidable mortality and morbidity...